Immunis

Neotis

This company develops immunotherapies targeting senescent cells to treat age-related and fibrotic diseases for patients with chronic conditions.

ImmuneAGE

This company develops a drug discovery platform for creating therapies that rejuvenate the immune system by targeting hematopoietic stem cells in the bone marrow.

Thymmune

This biotechnology company develops scalable thymic cell therapies to restore immune function for patients with immunodeficiencies, autoimmune disorders, and transplant-related conditions.

Juvena Therapeutics

This biotechnology company develops protein-based regenerative medicines for patients with chronic muscle and metabolic diseases.

Deciduous Therapeutics

This company develops small-molecule immunotherapies that activate the immune system to remove senescent cells for patients with age-related, metabolic and fibrotic diseases.

Immusoft

This clinical-stage biotechnology company develops engineered B cell therapies to treat patients suffering from rare inherited metabolic disorders and other chronic diseases.

IMEL Biotherapeutics

This company develops mitochondrial replacement cell therapies for patients with genetic mitochondrial disorders and age-related diseases.

Immutrin

This biotechnology company develops antibody therapies to remove amyloid deposits and treat cardiomyopathy for patients with amyloidosis.